“An Overview of Epidermodysplasia Verruciformis”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 11, no. 2, pp. 76–84, Apr. 2022, doi: 10.61096/ijrpp.v11.iss2.2022.76-84.